Holen Sie sich die Stockscreener-App
3.435
1.63%
0.055
Vorhandelsmarkt:
3.40
-0.035
-1.02%
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pal-Item
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria
Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - TipRanks
Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa
Processa Pharmaceuticals Completes Patient Enrollment for Phase 2 Clinical Study of NGC-Cap in Advanced Breast Cancer, Interim Data Expected Q1 2026 - Quiver Quantitative
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times
Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks making the biggest moves today - MSN
28.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):